Do analysts recommend CLB or PTEN?

Patterson-UTI Energy has a consensus target price of $12.15, indicating a potential upside of 29.12%. Given Patterson-UTI Energy's stronger consensus rating and higher probable upside, analysts clearly believe Patterson-UTI Energy is more favorable than Core Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Core Laboratories 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Patterson-UTI Energy 2 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.47

Does the media refer more to CLB or PTEN?

In the previous week, Patterson-UTI Energy had 24 more articles in the media than Core Laboratories. MarketBeat recorded 27 mentions for Patterson-UTI Energy and 3 mentions for Core Laboratories. Patterson-UTI Energy's average media sentiment score of 1.13 beat Core Laboratories' score of 0.22 indicating that Patterson-UTI Energy is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Core Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Patterson-UTI Energy 9 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CLB or HAL?

Halliburton has a consensus price target of $43.10, suggesting a potential upside of 34.10%. Given Halliburton's stronger consensus rating and higher possible upside, analysts plainly believe Halliburton is more favorable than Core Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Core Laboratories 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Halliburton 1 Sell rating(s) 6 Hold rating(s) 18 Buy rating(s) 0 Strong Buy rating(s) 2.68

Does the media refer more to CLB or HAL?

In the previous week, Halliburton had 67 more articles in the media than Core Laboratories. MarketBeat recorded 70 mentions for Halliburton and 3 mentions for Core Laboratories. Halliburton's average media sentiment score of 0.66 beat Core Laboratories' score of 0.22 indicating that Halliburton is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Core Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Halliburton 35 Very Positive mention(s) 8 Positive mention(s) 11 Neutral mention(s) 10 Negative mention(s) 2 Very Negative mention(s) Positive

Do analysts prefer CLB or HP?

Helmerich & Payne has a consensus price target of $39.80, indicating a potential upside of 18.44%. Given Helmerich & Payne's stronger consensus rating and higher probable upside, analysts clearly believe Helmerich & Payne is more favorable than Core Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Core Laboratories 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Helmerich & Payne 2 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media refer more to CLB or HP?

In the previous week, Helmerich & Payne had 20 more articles in the media than Core Laboratories. MarketBeat recorded 23 mentions for Helmerich & Payne and 3 mentions for Core Laboratories. Helmerich & Payne's average media sentiment score of 0.90 beat Core Laboratories' score of 0.22 indicating that Helmerich & Payne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Core Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Helmerich & Payne 8 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend MGY or CLB?

Magnolia Oil & Gas presently has a consensus target price of $31.42, suggesting a potential upside of 30.82%. Given Magnolia Oil & Gas' stronger consensus rating and higher possible upside, equities analysts clearly believe Magnolia Oil & Gas is more favorable than Core Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Magnolia Oil & Gas 0 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.47 Core Laboratories 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor MGY or CLB?

In the previous week, Magnolia Oil & Gas had 17 more articles in the media than Core Laboratories. MarketBeat recorded 20 mentions for Magnolia Oil & Gas and 3 mentions for Core Laboratories. Magnolia Oil & Gas' average media sentiment score of 0.81 beat Core Laboratories' score of 0.22 indicating that Magnolia Oil & Gas is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Magnolia Oil & Gas 10 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Core Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NBR or CLB?

Nabors Industries currently has a consensus price target of $100.57, indicating a potential upside of 27.77%. Given Nabors Industries' stronger consensus rating and higher possible upside, research analysts plainly believe Nabors Industries is more favorable than Core Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nabors Industries 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50 Core Laboratories 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer NBR or CLB?

In the previous week, Core Laboratories had 1 more articles in the media than Nabors Industries. MarketBeat recorded 3 mentions for Core Laboratories and 2 mentions for Nabors Industries. Nabors Industries' average media sentiment score of 0.37 beat Core Laboratories' score of 0.22 indicating that Nabors Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nabors Industries 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Core Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Core Laboratories (CLB) Competitors

$11.20 -0.47 (-3.99%)

Closing price 03:59 PM Eastern

Extended Trading

$11.23 +0.03 (+0.23%)

As of 06:45 PM Eastern

Compare

CLB vs. PTEN, HAL, HP, MGY, and NBR

Should you buy Core Laboratories stock or one of its competitors? MarketBeat compares Core Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Core Laboratories include Patterson-UTI Energy (PTEN), Halliburton (HAL), Helmerich & Payne (HP), Magnolia Oil & Gas (MGY), and Nabors Industries (NBR). These companies are all part of the "energy" sector.

How does Core Laboratories compare to Patterson-UTI Energy?

Core Laboratories (NYSE:CLB) and Patterson-UTI Energy (NASDAQ:PTEN) are both energy companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

Core Laboratories has higher earnings, but lower revenue than Patterson-UTI Energy. Patterson-UTI Energy is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$526.52M	0.98	$29.67M	$0.65	17.24
Patterson-UTI Energy	$4.83B	0.74	-$93.64M	-$0.31	N/A

Core Laboratories has a beta of 1, meaning that its share price has a similar volatility profile to the broader market.Comparatively, Patterson-UTI Energy has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Patterson-UTI Energy has a consensus target price of $12.15, indicating a potential upside of 29.12%. Given Patterson-UTI Energy's stronger consensus rating and higher probable upside, analysts clearly believe Patterson-UTI Energy is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Patterson-UTI Energy	2 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.47

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 97.9% of Patterson-UTI Energy shares are held by institutional investors. 1.3% of Core Laboratories shares are held by company insiders. Comparatively, 2.2% of Patterson-UTI Energy shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Patterson-UTI Energy had 24 more articles in the media than Core Laboratories. MarketBeat recorded 27 mentions for Patterson-UTI Energy and 3 mentions for Core Laboratories. Patterson-UTI Energy's average media sentiment score of 1.13 beat Core Laboratories' score of 0.22 indicating that Patterson-UTI Energy is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Patterson-UTI Energy	9 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Core Laboratories has a net margin of 5.94% compared to Patterson-UTI Energy's net margin of -2.56%. Core Laboratories' return on equity of 11.52% beat Patterson-UTI Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Patterson-UTI Energy	-2.56%	-2.32%	-1.37%

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Patterson-UTI Energy pays an annual dividend of $0.40 per share and has a dividend yield of 4.3%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Patterson-UTI Energy pays out -129.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Patterson-UTI Energy is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Patterson-UTI Energy beats Core Laboratories on 10 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Halliburton?

Core Laboratories (NYSE:CLB) and Halliburton (NYSE:HAL) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Core Laboratories has a beta of 1, meaning that its share price has a similar volatility profile to the broader market.Comparatively, Halliburton has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market.

Halliburton has higher revenue and earnings than Core Laboratories. Halliburton is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$526.52M	0.98	$29.67M	$0.65	17.24
Halliburton	$22.18B	1.21	$1.28B	$1.91	16.83

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Halliburton pays an annual dividend of $0.68 per share and has a dividend yield of 2.1%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Halliburton pays out 35.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Halliburton has raised its dividend for 4 consecutive years. Halliburton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 85.2% of Halliburton shares are held by institutional investors. 1.3% of Core Laboratories shares are held by company insiders. Comparatively, 0.6% of Halliburton shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Halliburton had 67 more articles in the media than Core Laboratories. MarketBeat recorded 70 mentions for Halliburton and 3 mentions for Core Laboratories. Halliburton's average media sentiment score of 0.66 beat Core Laboratories' score of 0.22 indicating that Halliburton is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Halliburton	35 Very Positive mention(s)	8 Positive mention(s)	11 Neutral mention(s)	10 Negative mention(s)	2 Very Negative mention(s)	Positive

Halliburton has a net margin of 7.16% compared to Core Laboratories' net margin of 5.94%. Halliburton's return on equity of 18.71% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Halliburton	7.16%	18.71%	7.89%

Halliburton has a consensus price target of $43.10, suggesting a potential upside of 34.10%. Given Halliburton's stronger consensus rating and higher possible upside, analysts plainly believe Halliburton is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Halliburton	1 Sell rating(s)	6 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.68

Summary

Halliburton beats Core Laboratories on 14 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Helmerich & Payne?

Core Laboratories (NYSE:CLB) and Helmerich & Payne (NYSE:HP) are both energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Helmerich & Payne had 20 more articles in the media than Core Laboratories. MarketBeat recorded 23 mentions for Helmerich & Payne and 3 mentions for Core Laboratories. Helmerich & Payne's average media sentiment score of 0.90 beat Core Laboratories' score of 0.22 indicating that Helmerich & Payne is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Helmerich & Payne	8 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 96.1% of Helmerich & Payne shares are held by institutional investors. 1.3% of Core Laboratories shares are held by insiders. Comparatively, 4.4% of Helmerich & Payne shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Core Laboratories has a net margin of 5.94% compared to Helmerich & Payne's net margin of -9.38%. Core Laboratories' return on equity of 11.52% beat Helmerich & Payne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Helmerich & Payne	-9.38%	-1.16%	-0.48%

Core Laboratories has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Helmerich & Payne has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

Helmerich & Payne has a consensus price target of $39.80, indicating a potential upside of 18.44%. Given Helmerich & Payne's stronger consensus rating and higher probable upside, analysts clearly believe Helmerich & Payne is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Helmerich & Payne	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Helmerich & Payne pays an annual dividend of $1.00 per share and has a dividend yield of 3.0%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Helmerich & Payne pays out -26.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Helmerich & Payne is clearly the better dividend stock, given its higher yield and lower payout ratio.

Core Laboratories has higher earnings, but lower revenue than Helmerich & Payne. Helmerich & Payne is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$526.52M	0.98	$29.67M	$0.65	17.24
Helmerich & Payne	$3.75B	0.90	-$163.70M	-$3.79	N/A

Summary

Core Laboratories and Helmerich & Payne tied by winning 9 of the 18 factors compared between the two stocks.

How does Core Laboratories compare to Magnolia Oil & Gas?

Magnolia Oil & Gas (NYSE:MGY) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Magnolia Oil & Gas presently has a consensus target price of $31.42, suggesting a potential upside of 30.82%. Given Magnolia Oil & Gas' stronger consensus rating and higher possible upside, equities analysts clearly believe Magnolia Oil & Gas is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Magnolia Oil & Gas	0 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Core Laboratories	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Magnolia Oil & Gas has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.

Magnolia Oil & Gas pays an annual dividend of $0.66 per share and has a dividend yield of 2.7%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.4%. Magnolia Oil & Gas pays out 38.4% of its earnings in the form of a dividend. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Magnolia Oil & Gas has raised its dividend for 3 consecutive years. Magnolia Oil & Gas is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Magnolia Oil & Gas had 17 more articles in the media than Core Laboratories. MarketBeat recorded 20 mentions for Magnolia Oil & Gas and 3 mentions for Core Laboratories. Magnolia Oil & Gas' average media sentiment score of 0.81 beat Core Laboratories' score of 0.22 indicating that Magnolia Oil & Gas is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Magnolia Oil & Gas	10 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

94.7% of Magnolia Oil & Gas shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 0.9% of Magnolia Oil & Gas shares are owned by insiders. Comparatively, 1.3% of Core Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Magnolia Oil & Gas has a net margin of 24.40% compared to Core Laboratories' net margin of 5.94%. Magnolia Oil & Gas' return on equity of 16.28% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Magnolia Oil & Gas	24.40%	16.28%	11.26%
Core Laboratories	5.94%	11.52%	5.32%

Magnolia Oil & Gas has higher revenue and earnings than Core Laboratories. Magnolia Oil & Gas is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Magnolia Oil & Gas	$1.31B	3.39	$325.25M	$1.72	13.96
Core Laboratories	$526.52M	0.98	$29.67M	$0.65	17.24

Summary

Magnolia Oil & Gas beats Core Laboratories on 14 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Nabors Industries?

Nabors Industries (NYSE:NBR) and Core Laboratories (NYSE:CLB) are both small-cap energy companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

Nabors Industries has a net margin of 7.32% compared to Core Laboratories' net margin of 5.94%. Core Laboratories' return on equity of 11.52% beat Nabors Industries' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nabors Industries	7.32%	-8.66%	-1.59%
Core Laboratories	5.94%	11.52%	5.32%

Nabors Industries has a beta of 0.96, suggesting that its share price is 4% less volatile than the broader market. Comparatively, Core Laboratories has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.

Nabors Industries currently has a consensus price target of $100.57, indicating a potential upside of 27.77%. Given Nabors Industries' stronger consensus rating and higher possible upside, research analysts plainly believe Nabors Industries is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nabors Industries	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Core Laboratories	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Core Laboratories had 1 more articles in the media than Nabors Industries. MarketBeat recorded 3 mentions for Core Laboratories and 2 mentions for Nabors Industries. Nabors Industries' average media sentiment score of 0.37 beat Core Laboratories' score of 0.22 indicating that Nabors Industries is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nabors Industries	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

81.9% of Nabors Industries shares are owned by institutional investors. Comparatively, 97.8% of Core Laboratories shares are owned by institutional investors. 5.3% of Nabors Industries shares are owned by company insiders. Comparatively, 1.3% of Core Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Nabors Industries has higher revenue and earnings than Core Laboratories. Nabors Industries is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nabors Industries	$3.21B	0.36	$286.62M	$12.77	6.16
Core Laboratories	$526.52M	0.98	$29.67M	$0.65	17.24

Summary

Nabors Industries beats Core Laboratories on 10 of the 17 factors compared between the two stocks.

Get Core Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLB vs. The Competition

Export

Metric	Core Laboratories	OIL Industry	Energy Sector	NYSE Exchange
Market Cap	$516.50M	$8.90B	$10.13B	$23.64B
Dividend Yield	0.34%	2.58%	11.41%	4.20%
P/E Ratio	17.24	21.58	19.26	31.20
Price / Sales	0.98	1.63	394.30	19.78
Price / Cash	10.92	11.46	36.61	18.54
Price / Book	1.92	2.79	4.10	4.78
Net Income	$29.67M	$373.98M	$4.25B	$1.07B
7 Day Performance	0.08%	-0.85%	0.22%	0.65%
1 Month Performance	2.27%	-2.09%	1.82%	0.26%
1 Year Performance	-4.45%	49.39%	27.44%	14.70%

Core Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLB Core Laboratories	2.4049 of 5 stars	$11.20 -4.0%	N/A	-0.4%	$516.50M	$526.52M	17.24	3,300	Upcoming Earnings Short Interest Decrease
PTEN Patterson-UTI Energy	4.4251 of 5 stars	$10.51 +4.0%	$12.15 +15.6%	+72.3%	$3.99B	$4.83B	N/A	7,900	Positive News Upcoming Earnings Options Volume Analyst Revision
HAL Halliburton	4.8984 of 5 stars	$33.07 -5.8%	$43.27 +30.9%	+48.3%	$27.65B	$22.18B	18.18	46,000	Earnings Report Analyst Downgrade Gap Down
HP Helmerich & Payne	3.2975 of 5 stars	$34.61 +2.7%	$39.80 +15.0%	+111.0%	$3.46B	$3.75B	N/A	6,200	News Coverage
MGY Magnolia Oil & Gas	4.1681 of 5 stars	$24.95 -2.3%	$31.75 +27.3%	+6.7%	$4.62B	$1.31B	14.53	210	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CLB) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Summary

How does Core Laboratories compare to Halliburton?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Summary

How does Core Laboratories compare to Nabors Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Which has better earnings & valuation, CLB or PTEN?

Which has more risk and volatility, CLB or PTEN?

Do analysts recommend CLB or PTEN?

Do insiders and institutionals hold more shares of CLB or PTEN?

Does the media refer more to CLB or PTEN?

Is CLB or PTEN more profitable?

Is CLB or PTEN a better dividend stock?

Summary

How does Core Laboratories compare to Halliburton?

Which has more volatility & risk, CLB or HAL?

Which has preferable valuation and earnings, CLB or HAL?

Is CLB or HAL a better dividend stock?

Do insiders & institutionals believe in CLB or HAL?

Does the media refer more to CLB or HAL?

Is CLB or HAL more profitable?

Do analysts rate CLB or HAL?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Does the media refer more to CLB or HP?

Do insiders and institutionals hold more shares of CLB or HP?

Is CLB or HP more profitable?

Which has more risk & volatility, CLB or HP?

Do analysts prefer CLB or HP?

Is CLB or HP a better dividend stock?

Which has stronger earnings & valuation, CLB or HP?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Do analysts recommend MGY or CLB?

Which has more risk & volatility, MGY or CLB?

Is MGY or CLB a better dividend stock?

Does the media favor MGY or CLB?

Do institutionals & insiders have more ownership in MGY or CLB?

Is MGY or CLB more profitable?

Which has better earnings and valuation, MGY or CLB?

Summary

How does Core Laboratories compare to Nabors Industries?

Is NBR or CLB more profitable?

Which has more volatility & risk, NBR or CLB?

Do analysts recommend NBR or CLB?

Does the media prefer NBR or CLB?

Do institutionals & insiders have more ownership in NBR or CLB?

Which has higher earnings & valuation, NBR or CLB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools